Showing results (261-270 of 3,348) with videos related to
Sort By:
Pageof 335
Pharmacoeconomics|November 11, 1999
Pharmacotherapeutic circles. Results of an 18-month peer-review prescribing-improvement programme for general practitionersL von Ferber, J Bausch, I Köster, et al.Pharmacoeconomics|January 6, 2000
Therapeutic options in the treatment of multiple myeloma: pharmacoeconomic and quality-of-life considerationsF Wisløff, N Gulbrandsen, E NordPharmacoeconomics|January 6, 2000
Clinical and economic considerations of empirical antibacterial therapy of febrile neutropenia in cancerG DranitsarisPharmacoeconomics|January 6, 2000
Costs of Mini Mental State Examination-related cognitive impairmentL Jönsson, P Lindgren, A Wimo, et al.Pharmacoeconomics|April 5, 2000
Formulary management of low molecular weight heparinsW E Wade, B C Martin, J A Kotzan, et al.Pharmacoeconomics|April 5, 2000
Economic evaluation of specific immunotherapy versus symptomatic treatment of allergic rhinitis in GermanyP K Schädlich, J G BrechtPharmacoeconomics|April 5, 2000
Use and cost of hospital and community service provision for children with HIV infection at an English HIV referral centreE J Beck, S Mandalia, R Griffith, et al.Pharmacoeconomics|June 1, 2001
Pharmacoeconomics of hypertension management: the place of combination therapyE AmbrosioniPharmacoeconomics|June 1, 2001
Cost-effectiveness analysis of n-3 polyunsaturated fatty acids (PUFA) after myocardial infarction: results from Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-Prevenzione TrialM G Franzosi, M Brunetti, R Marchioli, et al.Pageof 335